Laboratorios Edigen

Laboratorios Edigen is a Spanish pharmaceutical company specializing in the development and commercialization of generic medicinal products. Founded in 1963 and headquartered in Madrid, the company provides a broad range of high-quality, affordable therapeutic options across various categories, including cardiovascular, central nervous system, and gastrointestinal health. Edigen was previously part of Abbott Laboratories' established pharmaceutical products division before being acquired by Mylan in 2015. Following the 2020 merger between Mylan and Pfizer's Upjohn, Edigen now operates as a subsidiary of Viatris. The company is a significant contributor to the Spanish generic drug market, supporting the sustainability of the national healthcare system through its extensive portfolio of bioequivalent medicines.